Lv31
250 积分 2021-12-23 加入
Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study
2个月前
已完结
Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study
2个月前
已完结
SGLT2 Inhibitors and Mechanisms of Hypertension
2个月前
已完结
The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms
2个月前
已完结
Hypertension in China: epidemiology and treatment initiatives
3个月前
已完结
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
4个月前
已完结
Blood pressure‐lowering effects of GLP‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials
4个月前
已完结
[Clinical practice guidelines for the management of hypertension in China]
4个月前
已完结
The pathophysiology of hypertension in patients with obesity
4个月前
已关闭
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
4个月前
已完结
皖公网安备34019202002308
